Grant: UNIVERSITY OF KANSAS CENTER FOR RESEARCH, INC.
UNIVERSITY OF KANSAS CENTER FOR RESEARCH, INC.
CDFA Program Title
Trans-NIH Recovery Act Research Support
The 90 kDa heat shock proteins are proving to be extraordinary cancer chemotherapeutic targets as evidenced by the fact that more than 20 clinical trials are currently in progress. Unfortunately, all of these trials are based upon N-terminal inhibitors,
Recipients Connected to Award
|UNIVERSITY OF KANSAS CENTER FOR RESEARCH, INC.||Primary recipient||$512,710.00|
|UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE, INC.||Sub-recipient||$195,699.00|